Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantApoptosisAntineoplastic AgentsApoptosis Regulatory ProteinsCaspasesCisplatinCaspase 3Combined Modality TherapyDoxorubicinProto-Oncogene Proteins c-bcl-2Inhibitor of Apoptosis ProteinsCyclophosphamideCell Line, TumorTreatment OutcomeEtoposideBreast NeoplasmsDNA Fragmentationbcl-2-Associated X ProteinNeoadjuvant TherapyIn Situ Nick-End LabelingCell SurvivalX-Linked Inhibitor of Apoptosis ProteinDisease-Free SurvivalLung NeoplasmsNeoplasm StagingSurvival AnalysisDrug Resistance, NeoplasmApoptosis Inducing FactorTumor Suppressor Protein p53Signal TransductionPrognosisCASP8 and FADD-Like Apoptosis Regulating ProteinSurvival RateTumor Cells, CulturedPaclitaxelCaspase 9Caspase InhibitorsDrug Administration ScheduleTime FactorsAntineoplastic Agents, PhytogenicMethotrexateCaspase 8NeoplasmsMitochondriaDose-Response Relationship, DrugCarboplatinFas Ligand ProteinEnzyme ActivationCell ProliferationVinblastineCells, Culturedbcl-X ProteinCytochromes cTaxoidsInduction ChemotherapyAntimetabolites, AntineoplasticNeoplasm Recurrence, LocalFlow CytometryAnnexin A5Blotting, WesternCell CycleBleomycinDeoxycytidineIfosfamideProto-Oncogene ProteinsOrganoplatinum CompoundsAntibiotics, AntineoplasticCell LineOvarian NeoplasmsAdenocarcinomaCysteine Proteinase InhibitorsAntineoplastic Agents, AlkylatingCytarabineCarcinoma, Non-Small-Cell LungAmino Acid Chloromethyl KetonesPoly(ADP-ribose) PolymerasesEnzyme InhibitorsAnthracyclinesNeoplasm MetastasisGene Expression Regulation, NeoplasticCell DivisionImmunohistochemistryRNA, Small InterferingChemotherapy, Cancer, Regional PerfusionColorectal NeoplasmsFollow-Up StudiesSalvage TherapyCamptothecinTransfectionTNF-Related Apoptosis-Inducing LigandDrug SynergismReactive Oxygen SpeciesLiver NeoplasmsDown-RegulationCell DeathTesticular NeoplasmsJurkat CellsLymphoma, Non-HodgkinOsteosarcoma